Vendors

ELYRIA, Ohio – Invacare has completed the final milestones required to lift a consent decree with the U.S. Food and Drug Administration, paving the way for a re-inspection, the company announced April 27.

While monitoring has become ubiquitous in the sleep therapy market, where insurers require proof of compliance for continued reimbursement, the oxygen therapy market has been slower on the uptake.

Patrolling and enforcing prices online is an around-the-clock job, says Pam Springer, CEO of Oris Intelligence, a company that helps manufacturers enforce their minimum advertised pricing (MAP) programs.

DUBLIN, Ohio – Cardinal Health has entered into a definitive agreement to buy the patient care, deep vein thrombosis and nutritional inefficiency business of Medtronic for $6.1 billion in cash.